Article List

WPRIM Management System> DCMS> Korean Journal of Clinical Pharmacy> 2021> 31> 3

Volume: 31 Issue: 3

1. Arthralgia and Myalgia Associated with the Use of Bisphosphonate:An Active Monitoring Study	Page:180—187
2. European Regulatory Science and Regulatory Science Expert Training Project	Page:171—179
3. Usage Patterns and Incidence of Thyroid-related Adverse Events in Patients Treated with PD-1 Inhibitors	Page:188—197
4. Atherosclerotic Cardiovascular Disease Risk and Statin Prescription Status in Korean Adult Patients	Page:198—204
5. Effectiveness and Safety Verification of Brinzolamide Combination Therapy on Primary Open-angle Glaucoma or Ocular Hypertension: A Systematic Review and Meta-analysis Study	Page:205—215
6. Comparison of National Database of Health Inequality between Korea and the UK:Focusing on Substance Misuse Related Mental Health and Respiratory Diseases	Page:216—230
7. An Analysis on Distribution of Handgrip Strength and Associated Factors in Korean Adults	Page:231—236
8. Analysis of Pembrolizumab-induced Blood Glucose Level Change in Cancer Patients	Page:237—246
9. Arthralgia and Myalgia Associated with the Use of Bisphosphonate:An Active Monitoring Study	Page:180—187
10. European Regulatory Science and Regulatory Science Expert Training Project	Page:171—179
11. Analysis of Pembrolizumab-induced Blood Glucose Level Change in Cancer Patients	Page:237—246
12. An Analysis on Distribution of Handgrip Strength and Associated Factors in Korean Adults	Page:231—236
13. Comparison of National Database of Health Inequality between Korea and the UK:Focusing on Substance Misuse Related Mental Health and Respiratory Diseases	Page:216—230
14. Effectiveness and Safety Verification of Brinzolamide Combination Therapy on Primary Open-angle Glaucoma or Ocular Hypertension: A Systematic Review and Meta-analysis Study	Page:205—215
15. Atherosclerotic Cardiovascular Disease Risk and Statin Prescription Status in Korean Adult Patients	Page:198—204
16. Usage Patterns and Incidence of Thyroid-related Adverse Events in Patients Treated with PD-1 Inhibitors	Page:188—197